Drug Patents owned by Eyevance

1. List of Tobradex St drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8450287 EYEVANCE Topical ophthalmic compositions containing tobramycin and dexamethasone
Dec, 2027

(4 years from now)

US8101582 EYEVANCE Topical ophthalmic compositions containing tobramycin and dexamethasone
Dec, 2027

(4 years from now)

US7795316 EYEVANCE Topical ophthalmic compositions containing tobramycin and dexamethasone
Aug, 2028

(5 years from now)

Drugs and Companies using DEXAMETHASONE; TOBRAMYCIN ingredient

Market Authorisation Date: 13 February, 2009

Treatment: Use of a combination of tobramycin and dexamethasone to treat ocular inflammation where an infection or risk of infection exists

Dosage: SUSPENSION/DROPS;OPHTHALMIC

More Information on Dosage

2. List of Zerviate drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9993471 EYEVANCE Ophthalmic formulations of cetirizine and methods of use
Mar, 2030

(7 years from now)

US8829005 EYEVANCE Ophthalmic formulations of cetirizine and methods of use
Mar, 2030

(7 years from now)

US9750684 EYEVANCE Ophthalmic formulations of cetirizine and methods of use
Mar, 2030

(7 years from now)

US8829005

(Pediatric)

EYEVANCE Ophthalmic formulations of cetirizine and methods of use
Sep, 2030

(7 years from now)

US9254286 EYEVANCE Ophthalmic formulations of cetirizine and methods of use
Jul, 2032

(9 years from now)

US9254286

(Pediatric)

EYEVANCE Ophthalmic formulations of cetirizine and methods of use
Jan, 2033

(9 years from now)

Drugs and Companies using CETIRIZINE HYDROCHLORIDE ingredient

Market Authorisation Date: 30 May, 2017

Treatment: Treatment of ocular itching associated with allergic conjunctivitis

Dosage: SOLUTION/DROPS;OPHTHALMIC

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic